Trial Profile
A phase Ib placebo-controlled, double blind study to investigate safety, tolerability and pharmacokinetics of VAS203 after repetitive dosing
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 27 Aug 2015
Price :
$35
*
At a glance
- Drugs Ronopterin (Primary)
- Indications Brain injuries
- Focus Adverse reactions
- 27 Aug 2015 New trial record